ArticleBlood advances2023
Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study.
Stuart Scott et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it